Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dapagliflozin”

516 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 516 results

Not applicableLooking for participantsNCT06165601
What this trial is testing

Proteinuria in Renal Transplant Patients Treated with Dapagliflozin

Who this might be right for
Chronic Kidney Diseases
University Hospital, Montpellier 70
Testing effectiveness (Phase 2)Looking for participantsNCT07239011
What this trial is testing

Dapagliflozin in Depression

Who this might be right for
Depression
Tanta University 60
Large-scale testing (Phase 3)Study completedNCT02284893
What this trial is testing

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 461
Early research (Phase 1)Study completedNCT00688493
What this trial is testing

Effects of Single Oral Dose Dapagliflozin QT Study

Who this might be right for
Healthy
AstraZeneca 36
Post-approval studies (Phase 4)Study completedNCT03970044
What this trial is testing

Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.

Who this might be right for
Diabetes Mellitus, Type 2
Consano Clinical Research, LLC 67
Testing effectiveness (Phase 2)UnknownNCT05420285
What this trial is testing

Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction

Who this might be right for
Heart FailureReduced Ejection Fraction
Assistance Publique - Hôpitaux de Paris 40
Testing effectiveness (Phase 2)Looking for participantsNCT07222917
What this trial is testing

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

Who this might be right for
Chronic Kidney Disease and Hypertension
AstraZeneca 218
Large-scale testing (Phase 3)Active Not RecruitingNCT07214818
What this trial is testing

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mansoura University 75
Early research (Phase 1)Study completedNCT00562250
What this trial is testing

Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 11
Large-scale testing (Phase 3)Study completedNCT04400760
What this trial is testing

The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.

Who this might be right for
Platelet Dysfunction
The University of The West Indies 40
Post-approval studies (Phase 4)Study completedNCT06721442
What this trial is testing

Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study

Who this might be right for
Arrhythmias, CardiacDiabetes Mellitus
Beneficência Portuguesa de São Paulo 174
Post-approval studies (Phase 4)Study completedNCT04792190
What this trial is testing

Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University of Rochester 25
Testing effectiveness (Phase 2)UnknownNCT04304560
What this trial is testing

Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial

Who this might be right for
Heart Failure With Reduced Ejection Fraction (HFrEF)Diabete Type 2Cardiomyopathies
Damanhour University 60
Post-approval studies (Phase 4)WithdrawnNCT04531397
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Who this might be right for
ProteinuriaChronic Kidney Diseases
Children's Hospital of Fudan University
Post-approval studies (Phase 4)Looking for participantsNCT06499948
What this trial is testing

Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients with Alport Syndrome (COMBINE-ALPORT)

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseAlport Nephropathy
Stefan Lujinschi 34
Testing effectiveness (Phase 2)Study completedNCT02313220
What this trial is testing

Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight

Who this might be right for
Obesity
Uppsala University 50
Large-scale testing (Phase 3)Study completedNCT04350593
What this trial is testing

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Who this might be right for
COVID-19
Saint Luke's Health System 1,250
Post-approval studies (Phase 4)Study completedNCT06026787
What this trial is testing

Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeSodium-Glucose Transporter 2 Inhibitors
Ain Shams University 60
Not applicableStudy completedNCT04215523
What this trial is testing

Replication of the DECLARE Diabetes Trial in Healthcare Claims

Who this might be right for
Diabetes
Brigham and Women's Hospital 49,790
Not applicableStudy completedNCT07338331
What this trial is testing

Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Diabete Type 2Non Alcoholic Fatty Liver
Galala University 80
Load More Results